Pangaea Biotech Overview
- Founded
- 2007
- Status
- Public
- Employees
- 51
- Stock Symbol
- PANG
- Share Price
- $1.90
- (As of Monday Closing)
Pangaea Biotech General Information
Description
Pangaea Oncology SA is a medical services company. The company provides a wide range of services to cancer patients, as well as global pharmaceutical and biotech clients, in the fields of molecular diagnostics, clinical trials, in vitro drug profiling, dx platform validation, and biomarker discovery. The company has aggregated its operations into two segments, Clinical Care division and Diagnostic and Research and Development services division. Clinical Care division delivers medical oncology services and related activities. Diagnostic and Research and Development services division provides diagnostic and in-vitro services.
Contact Information
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Drug Discovery
Stock Exchange
XMAD
Primary Office
- C/Sabino Arana, 5-19
- 08028 Barcelona
- Spain
+34 935 00 00 00
Pangaea Biotech Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.90 | $1.91 | $1.14 - $1.99 | $24.9M | 3.71K | -$0.14 |
Pangaea Biotech Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 |
|---|---|---|---|---|
| EV | 32,736 | 34,466 | 31,662 | |
| Revenue | 3,409 | 3,609 | 2,957 | 2,785 |
| EBITDA | 1,166 | 872 | (1,025) | (258) |
| Net Income | (1,798) | (1,478) | (1,857) | (658) |
| Total Assets | 20,944 | 23,282 | 22,742 | 18,866 |
| Total Debt | 4,963 | 5,441 | 5,416 | 3,743 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Pangaea Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Pangaea Biotech‘s full profile, request access.
Request a free trialPangaea Biotech Executive Team (3)
Pangaea Biotech Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000ú0 00000 000é000 | Pangaea Biotech | Board Member | 000 0000 |
| 0000 0000000 00 | Pangaea Biotech | Board Member | 000 0000 |
| 000000 0ó000-00é0000 | Pangaea Biotech | Board Member | 000 0000 |
| 000000 000000 00.0 | Pangaea Biotech | Co-Founder, Chief Scientific Officer, Chairman & Member of Scientific Committee | 000 0000 |
| 00000000 00000 0 00000 00 | Pangaea Biotech | Co-Founder, Vice-President & Director, Molecular Pathology | 000 0000 |
Pangaea Biotech Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial